Acrivon Therapeutics CEO Peter Blume-Jensen's 2022 pay jumps 2,765% to $22M
Acrivon Therapeutics reports 2022 executive compensation
By ExecPay News
Published: May 1, 2023
Acrivon Therapeutics reported fiscal year 2022 executive compensation information on May 1, 2023.
In 2022, three executives at Acrivon Therapeutics received on average a compensation package of $8.5M, a 1,298% increase compared to previous year.
Average pay of disclosed executives at Acrivon Therapeutics
Peter Blume-Jensen, Chief Executive Officer, received $22M in total, which increased by 2,765% compared to 2021. 86% of Blume-Jensen's compensation, or $19M, was in stock awards. Blume-Jensen also received $470K in non-equity incentive plan, $2M in option awards, as well as $536K in salary.
Eric Devroe, Chief Operating Officer, received a compensation package of $2.2M, which increased by 371% compared to previous year. 53% of the compensation package, or $1.1M, was in option awards.
Rasmus Holm-Jorgensen, Chief Financial Officer, earned $1.7M in 2022.
Related executives
You may also like
Source: SEC filing on May 1, 2023.